AVITA Medical Q4 2024 Earnings Report $8.37 +0.05 (+0.60%) As of 03/11/2025 04:00 PM Eastern Earnings HistoryForecast AVITA Medical EPS ResultsActual EPS-$0.44Consensus EPS -$0.30Beat/MissMissed by -$0.14One Year Ago EPSN/AAVITA Medical Revenue ResultsActual Revenue$18.41 millionExpected Revenue$18.40 millionBeat/MissBeat by +$10.00 thousandYoY Revenue GrowthN/AAVITA Medical Announcement DetailsQuarterQ4 2024Date2/13/2025TimeAfter Market ClosesConference Call ResourcesConference CallConference Call TranscriptSlide DeckPress ReleaseRCEL Earnings HistorySlide DeckFull Screen Slide DeckPowered by Remove Ads AVITA Medical Earnings HeadlinesAvita Medical management to meet with Lake StreetFebruary 27, 2025 | markets.businessinsider.comAVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care ConferenceFebruary 26, 2025 | globenewswire.comNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the market… Unleashing more explosive moves than ever before.March 12, 2025 | Timothy Sykes (Ad)Avita Medical price target lowered to $22 from $25 at D. Boral CapitalFebruary 20, 2025 | markets.businessinsider.comAVITA Medical, Inc. (RCEL): A Bull Case TheoryFebruary 20, 2025 | insidermonkey.comAfter Sales Rebound In January, AVITA Is Set Up For A Monster YearFebruary 18, 2025 | seekingalpha.comSee More AVITA Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like AVITA Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AVITA Medical and other key companies, straight to your email. Email Address About AVITA MedicalAVITA Medical (NASDAQ:RCEL), together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.View AVITA Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles These 3 Q1 Earnings Winners Will Go HigherAnalysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before Earnings Upcoming Earnings PDD (3/19/2025)Micron Technology (3/20/2025)Accenture (3/20/2025)FedEx (3/20/2025)NIKE (3/20/2025)Cintas (3/26/2025)Paychex (4/1/2025)Bank of New York Mellon (4/11/2025)BlackRock (4/11/2025)JPMorgan Chase & Co. (4/11/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
